Kim Custeau, AVEVA’s executive vice president of portfolio discusses AI, hybrid cloud infrastructure and operational data.
Bristol Myers Squibb (BMY) looks undervalued: 4 near-term pipeline catalysts and DCF imply ~20% upside, plus 4.35% yield.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results